Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.
Toussaint ND, Elder GJ, Kerr PG. Clin J Am Soc Nephrol. 2009 Jan;4(1):221-33
Related Articles:
- Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease.
- Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of Randomized Trials.
- KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD–MBD)
Recent Comments